Home › Interstitial Lung Diseases › Mississippi
Interstitial Lung Diseases clinical trials in Mississippi
3 studies for Interstitial Lung Diseases are looking for participants at sites in Mississippi.
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Mississippi Medical Center, Jackson
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Mississippi Medical Center, Jackson
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Memorial Hospital at Gulfport, Gulfport
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05943535From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.